Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Abortion, Habitual D000026 5 associated lipids
Acidosis D000138 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Airway Obstruction D000402 13 associated lipids
Albuminuria D000419 18 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Aortic Rupture D001019 3 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Asthenia D001247 5 associated lipids
Asthma D001249 52 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bartter Syndrome D001477 5 associated lipids
Behcet Syndrome D001528 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Bluetongue D001819 1 associated lipids
Body Weight D001835 333 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchitis D001991 6 associated lipids
Bronchopneumonia D001996 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Byssinosis D002095 11 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat Diseases D002371 12 associated lipids
Cattle Diseases D002418 24 associated lipids
Celiac Disease D002446 16 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Chediak-Higashi Syndrome D002609 4 associated lipids
Chest Pain D002637 4 associated lipids
Choline Deficiency D002796 16 associated lipids
Cleft Palate D002972 9 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Contusions D003288 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Coronary Vasospasm D003329 9 associated lipids
Cough D003371 19 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diseases in Twins D004200 4 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drowning D004332 2 associated lipids
Ductus Arteriosus, Patent D004374 5 associated lipids
Edema D004487 152 associated lipids
Edema, Cardiac D004489 1 associated lipids
Embolism, Fat D004620 4 associated lipids
Endometriosis D004715 29 associated lipids
Enteritis D004751 8 associated lipids
Erythromelalgia D004916 1 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Eye Burns D005126 13 associated lipids
Facial Pain D005157 5 associated lipids
Fatty Liver D005234 48 associated lipids
Femoral Fractures D005264 7 associated lipids
Fetal Diseases D005315 8 associated lipids
Fever D005334 35 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Fibrosis D005355 23 associated lipids
Fistula D005402 8 associated lipids
Foot Rot D005535 1 associated lipids
Frostbite D005627 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Moodley J et al. Amniotic fluid prostanoids in preeclampsia. 1984 Obstet Gynecol pmid:6547518
Carter AJ et al. Human pulmonary vessels obtained from necropsy produce less prostacyclin and thromboxane than fresh vessels obtained from operations. 1984 Thromb. Res. pmid:6547546
Takeda H et al. [A comparison of centrifugal and roller pumps. An experimental study]. 1984 Kyobu Geka pmid:6547750
Cooper C et al. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. 1984 J. Neurol. Neurosurg. Psychiatr. pmid:6330309
Carter AJ et al. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. 1984 Thromb. Haemost. pmid:6377567
Salvetti A et al. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. 1984 Br J Clin Pharmacol pmid:6378233
Kirton OC et al. The development of a model of subacute lung injury after intra-abdominal infection. 1984 Surgery pmid:6379962
Luderer JR et al. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon. 1984 Clin. Pharmacol. Ther. pmid:6428793
Watanabe J et al. Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus. 1984 Tohoku J. Exp. Med. pmid:6515648
Ditter H and Matthias FR Changes in thromboxane formation by platelets during and after a continuous endotoxin infusion into rabbits. 1984 VASA pmid:6516562
Fitscha P et al. Follow-up of in-vivo platelet function (platelet half-life, thromboxane B2) in patients with coronary heart disease. 1984 VASA pmid:6516563
Block HU et al. Estimation of thromboxane B2 in the clotting human whole blood by gas chromatography. 1984 Biomed. Biochim. Acta pmid:6517904
Hornych A et al. [Changes in plasma prostaglandins in normal subjects in an orthostatic position. Comparison with the response of the renin-aldosterone system]. 1984 Presse Med pmid:6242503
Schieppati A et al. The metabolism of arachidonic acid by platelets in nephrotic syndrome. 1984 Kidney Int. pmid:6434788
Tanganelli I et al. Effects of somatostatin on the behavior of thromboxane B2 and B-thromboglobulin in type 1 diabetes. 1984 Boll. Soc. Ital. Biol. Sper. pmid:6084513
Lewis GP and Smith JR Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo. 1984 Prostaglandins pmid:6435186
Simberg N Maternal aspirin administration inhibits pulmonary arachidonic acid metabolism in fetal rabbits. 1984 Prostaglandins Leukot Med pmid:6425868
Rao GH et al. Enteric-coated aspirin, platelet cyclooxygenase activity and function. 1984 Prostaglandins Leukot Med pmid:6425869
Burghuber O et al. Lung edema due to hydrogen peroxide is independent of cyclooxygenase products. 1984 J Appl Physiol Respir Environ Exerc Physiol pmid:6427146
Steel LK et al. In vitro prostaglandin release from guinea pig parenchymal lung tissues is not stimulated by thymic peptides. 1984 Int. J. Immunopharmacol. pmid:6427124
Schafer AI et al. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. 1984 J. Clin. Invest. pmid:6423665
Krell RD and Kusner EJ Differential effect of cyclo-oxygenase inhibition on antigen- and ionophore-induced release of slow reacting substance from fragmented guinea-pig lung. 1984 Br. J. Pharmacol. pmid:6434013
Jouve R et al. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. 1984 Am. Heart J. pmid:6581715
Ylikorkala O and Tenhunen A Follicular fluid prostaglandins in endometriosis and ovarian hyperstimulation. 1984 Fertil. Steril. pmid:6363141
Lefer AM et al. Pathophysiological mechanisms of sudden death induced by platelet activating factor. 1984 Br. J. Pharmacol. pmid:6435705
Cremer KF et al. Effects of diltiazem, dipyridamole, and their combination on hemostasis. 1984 Clin. Pharmacol. Ther. pmid:6435926
Marks JG et al. Contact urticaria and airway obstruction from carbonless copy paper. 1984 Aug 24-31 JAMA pmid:6235381
MacNab MW et al. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. 1984 Feb-Mar J Clin Pharmacol pmid:6371062
Buchanan MR and Hirsh J Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. 1984 Jul-Aug Arteriosclerosis pmid:6380468
Paajanen H et al. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. 1984 Jul-Aug Invest Radiol pmid:6434489
De Caterina R et al. Thromboxane-B2 generation during ex-vivo platelet aggregation. 1984 Jul-Sep J. Nucl. Med. Allied Sci. pmid:6530623
Egg D Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. 1984 Mar-Apr Z Rheumatol pmid:6730731
Tanabe M et al. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202970
Laustiola K et al. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202971
Sturm M et al. The measurement of plasma thromboxane B2 and the effect of smoking. 1984 Nov-Dec Clin. Exp. Pharmacol. Physiol. pmid:6536421
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Uderman HD et al. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. 1984 Sep-Oct J. Cardiovasc. Pharmacol. pmid:6209508
Halushka PV et al. Insulin and arachidonic acid metabolism in diabetes mellitus. 1985 Metab. Clin. Exp. pmid:3934501
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Bakhle YS and Grantham CJ Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung. 1985 Biochem. Pharmacol. pmid:3935117
Hugli TE and Marceau F Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. 1985 Br. J. Pharmacol. pmid:3921089
Panse M et al. An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets. 1985 Prostaglandins pmid:3937179
Toivanen J et al. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro. 1985 Thromb. Res. pmid:3920778
Heinz TR et al. Radiation-induced alterations in cyclooxygenase product synthesis by isolated perfused rat lungs. 1985 Prog Biochem Pharmacol pmid:3921980
Lauri D et al. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. 1985 J. Lab. Clin. Med. pmid:3923145
Yamaguchi M and Mori N 6-Keto prostaglandin F1 alpha, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period. 1985 Am. J. Obstet. Gynecol. pmid:3838119
Johnson A and Malik AB Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors. 1985 Am. Rev. Respir. Dis. pmid:3925828
Packham MA et al. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. 1985 Blood pmid:3926022
Patrono C et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 1985 J. Clin. Invest. pmid:3900132
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Aitokallio-Tallberg A et al. Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. 1985 Br. J. Cancer pmid:2986666
Callahan KS et al. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. 1985 Circulation pmid:2986877
Schmitz JM et al. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. 1985 Circ. Res. pmid:3926340
Apprill P et al. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. 1985 Circulation pmid:2988822
Wong C et al. Effect of a body burn on the lung response to endotoxin. 1985 J Trauma pmid:3880823
Khirabadi BS et al. Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection. 1985 Transplantation pmid:3880966
Mehta J and Mehta P Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. 1985 Am. Heart J. pmid:3880988
Friedrich T et al. Follow-up of prostaglandin plasma levels after acute myocardial infarction. 1985 Am. Heart J. pmid:3880994
Wilson TW and Tan LK Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. 1985 Diabetes pmid:3881302
Shephard EG et al. Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. 1985 Br J Clin Pharmacol pmid:2581599
Addonizio VP et al. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation. 1985 J. Thorac. Cardiovasc. Surg. pmid:2582210
McGowan HM et al. The effect of dietary alteration of prostaglandin synthesis on blood pressure and the reversal of hypertension in the one-kidney, one-clip rat. 1985 Prostaglandins pmid:3859891
Granström E et al. Monitoring thromboxane production in vivo: metabolic and analytical aspects. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936194
FitzGerald GA et al. Analysis of urinary metabolites of thromboxane and prostacyclin by negative-ion chemical-ionization gas chromatography/mass spectrometry. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936207
Kuzuya T et al. Determination of plasma thromboxane B2 by radioimmunoassay: methodological problems and accuracy. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936210
Slotman GJ et al. Thromboxane and prostacyclin in clinical acute respiratory failure. 1985 J. Surg. Res. pmid:3892164
Hsu CY et al. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. 1985 Neurology pmid:3892363
Morita I et al. Effect of dietary protein level on platelet aggregation in rat. 1985 Prostaglandins Leukot Med pmid:3892545
de Lorgeril M et al. Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life. 1985 Eur. Heart J. pmid:2937635
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Paajanen H and Kormano M Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT. 1985 Eur J Radiol pmid:3896802
von Schacky C et al. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. 1985 J. Clin. Invest. pmid:2997286
Codde JP and Beilin LJ Dietary fish oil prevents dexamethasone induced hypertension in the rat. 1985 Clin. Sci. pmid:3905217
Mundie TG et al. Byssinosis: Release of prostaglandins, thromboxane, and 5-hydroxytryptamine in bronchopulmonary lavage fluid after inhalation of cotton dust extracts. 1985 Am. J. Pathol. pmid:3966532
Higashihara M et al. A monoclonal anti-human platelet antibody: a new platelet aggregating substance. 1985 Blood pmid:3967086
Nawroth PP et al. Thromboxane production by perturbed bovine aortic endothelial cells in culture. 1985 Blut pmid:3967102
Martin JL et al. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. 1985 J. Am. Coll. Cardiol. pmid:3968305
De Caterina R et al. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. 1985 Thromb. Res. pmid:3975876
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Westenfelder C et al. Renal function in calves with total artificial hearts. 1985 Trans Am Soc Artif Intern Organs pmid:3837477
Schrör K et al. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. 1985 Klin. Wochenschr. pmid:3838352
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Lorenz RR and Vanhoutte PM Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels. 1985 Am. J. Physiol. pmid:4037113
Remuzzi G et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. 1985 J. Clin. Invest. pmid:4038407
Vinge E et al. Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation. 1985 Acta Pharmacol Toxicol (Copenh) pmid:3840639
Mogensen F et al. Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. 1985 Thromb. Res. pmid:4038824
Bennett A et al. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo. 1985 Br. J. Pharmacol. pmid:3840708
Tada M et al. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. 1985 Int. J. Cardiol. pmid:4040500
Lorenzana RM et al. Experimental T-2 toxicosis in swine. I. Changes in cardiac output, aortic mean pressure, catecholamines, 6-keto-PGF1 alpha, thromboxane B2, and acid-base parameters. 1985 Fundam Appl Toxicol pmid:3840756
Wargovich T et al. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. 1985 J. Am. Coll. Cardiol. pmid:4045029
Feuerstein G et al. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. 1985 Circ. Shock pmid:3841032
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
Dejana E et al. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. 1985 Proc. Soc. Exp. Biol. Med. pmid:3841210
Fiedler VB et al. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury. 1985 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3841382
Palmer RM and Salmon JA Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. 1985 Biochem. Pharmacol. pmid:2986647
Lynch TJ et al. Carbon tetrachloride-induced eicosanoid synthesis and enzyme release from rat peritoneal leucocytes. 1985 Biochem. Pharmacol. pmid:2986650
Armstrong RA et al. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep. 1985 Prostaglandins pmid:2989977
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563